Media Release: Medicine access for all? Just more of the same.
May 1, 2025
By Christine Cockburn CEO, Rare Cancers Australia, 1st May 2025 Right now,…
Read more arrow_forwardUpdates
By Christine Cockburn CEO, Rare Cancers Australia, 1st May 2025 Right now,…
Read more arrow_forward
For many, Christmas is a time of celebration, family gatherings, indulgent food…
Read more arrow_forward1. What is HTA? Health Technology Assessment (HTA) is a set of…
Read more arrow_forwardNational not-for-profit organisation Omico is hosting a webinar later this month to help people learn more about comprehensive genomic profiling, precision oncology and how they could benefit.
Read more arrow_forwardWhen her daughter was just three years old, Lillian was diagnosed with non-small cell lung cancer.
Read more arrow_forward
Rare Cancers Australia (RCA) wishes to announce that Richard Vines will step down from his role as Chief Executive, effective 31 December 2023. Ms Christine Cockburn will assume the role as Chief Executive effective 1 January 2024.
Read more arrow_forward
At Rare Cancers Australia, we believe the value of a treatment needs to look beyond the dollars on the price tag.
Read more arrow_forward
This March, RCA Chief Executive Richard Vines was invited to speak at…
Read more arrow_forward
By Beth Doggett Specialist Cancer Navigator One of the concerns that is…
Read more arrow_forward
There is no more crushing news for a cancer patient to hear than; “there is treatment that can help you, but it is not funded by the PBS." This means the cost to the patient could be up to and at times more than $100,000 per year.
Read more arrow_forward